信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·江中药业：每10股派6元 股权登记日为11月24日2023-11-21 0:54:56
·股票行情快报：汉森制药（002412）11月20日主力资金净卖出792.63万元2023-11-20 23:05:26
·亿帆医药：首次回购公司股份723300股2023-11-20 22:56:28
·瑞兴医药拟设立分公司进一步优化公司战略布局2023-11-20 22:52:31
·誉衡药业：刁秀强辞去公司董事、执行总经理等职务2023-11-20 22:02:56
·医药生物行业周报：慢病防治方案发布，关注相关投资机会2023-11-20 19:39:08
·东诚药业：控股子公司获得药物临床试验批准2023-11-20 19:39:01
·艾迪药业：公司在研1类新药艾诺韦林片新增适应症拟纳入优先审评程序2023-11-20 19:34:54
·2023年11月第三周创新药周报（附小专题AKT靶点研发概况）2023-11-20 19:30:47
·复星医药：控股子公司获药品临床试验批准2023-11-20 19:13:13
·医药与健康护理行业周报：2023年国家医保谈判工作正式启动，关注创新药及具备性价比的大药企2023-11-20 18:41:24
·艾迪药业：艾诺韦林片新增适应症拟纳入优先审评程序2023-11-20 18:41:01
·医药生物行业周报：医保谈判进行时，关注大产品受益医保快速放量标的2023-11-20 17:22:05
·苑东生物：布洛芬注射液获得药品注册证书2023-11-20 17:13:04
·仟源医药（300254）11月20日主力资金净买入1382.77万元2023-11-20 17:05:36
·多瑞医药：全资子公司获得药品注册证书2023-11-20 16:52:10
·接连签约核药、手术导航创新产品！百洋医药商业化平台创新发展全面提速2023-11-20 15:38:11
·罗欣药业：替戈拉生片新适应症获批 进一步增强公司市场竞争力2023-11-20 15:34:01
·医药生物行业周报：医保谈判揭晓在即，需关注具备创新品类的标的2023-11-20 13:59:46
·医药生物行业周报：创新出海打开市场空间，海外高壁垒筛选优秀标的2023-11-20 13:47:17

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]